Business Wire IndiaWipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced they have been selected by Independent Health, Western New York’s only 5-Star Rated Medicare Advantage Plan, to implement Wipro’s Medicare Prescription Payment Plan (MPPP360) platform for the upcoming open enrollment period.
  
Starting in 2025, the Medicare Prescription Payment Plan will allow enrollees to make capped monthly payments for out-of-pocket prescription drugs, amongst other changes. The new law aims to improve access to affordable treatments and strengthen Medicare.
 
Wipro’s MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions, simplifying prescription cost management for Medicare recipients in Western New York.  
  
Narayan Iyer, Vice President, Healthcare, Wipro Limited, said “We are excited to introduce our Medicare Prescription Payment Plan360 platform, better known as MPPP360, to Western New York. This project exemplifies our dedication to transforming the Medicare landscape through innovative technology solutions. Together with Independent Health, we are committed to enhancing efficiency and convenience for beneficiaries, thereby elevating their healthcare journey.”
  
“Independent Health prides itself on being a leading, highly rated, Medicare Advantage plan. With the forthcoming changes to Medicare Part D, and the pharmaceutical industry’s continued escalation of prescription drug pricing, we want to make sure our members can afford their medications. It is important that our members have access to their medications and take them as prescribed to maintain their health and well-being,” said Dawn Odrzywolski, Vice President, Medicare Programs, Independent Health. “This prescription drug payment program complements our efforts to provide our members with innovative solutions to meet their varying healthcare needs, which in turn supports our efforts in achieving our industry leading 5-Star rating from CMS for three consecutive years.”